Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: Results from a randomized study

This randomized, partially-blind study (ClinicalTrials.gov registration number NCT00541970) evaluated the immunogenicity and safety of 2-dose (2D) schedules of the HPV-16/18 AS04-adjuvanted vaccine. Results to month (M) 24 have been reported previously and we now report data to M48 focusing on the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Romanowski, Barbara, Schwarz, Tino F, Ferguson, Linda M, Ferguson, Murdo, Peters, Klaus, Dionne, Marc, Schulze, Karin, Ramjattan, Brian, Hillemanns, Peter, Behre, Ulrich, Suryakiran, Pemmaraju, Thomas, Florence, Struyf, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896558/
https://www.ncbi.nlm.nih.gov/pubmed/24576907
http://dx.doi.org/10.4161/hv.28022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896558/
https://www.ncbi.nlm.nih.gov/pubmed/24576907
http://dx.doi.org/10.4161/hv.28022

Ejemplares similares